BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34304566)

  • 21. Recent Advances in Upconversion Nanoparticles-Based Multifunctional Nanocomposites for Combined Cancer Therapy.
    Tian G; Zhang X; Gu Z; Zhao Y
    Adv Mater; 2015 Dec; 27(47):7692-712. PubMed ID: 26505885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combating Concentration Quenching in Upconversion Nanoparticles.
    Chen B; Wang F
    Acc Chem Res; 2020 Feb; 53(2):358-367. PubMed ID: 31633900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancements and applications of upconversion nanoparticles in wound dressings.
    Gültekin HE; Yaşayan G; Bal-Öztürk A; Bigham A; Simchi AA; Zarepour A; Iravani S; Zarrabi A
    Mater Horiz; 2024 Jan; 11(2):363-387. PubMed ID: 37955196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upconversion nanoparticles: from hydrophobic to hydrophilic surfaces.
    Muhr V; Wilhelm S; Hirsch T; Wolfbeis OS
    Acc Chem Res; 2014 Dec; 47(12):3481-93. PubMed ID: 25347798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance.
    Tian G; Zheng X; Zhang X; Yin W; Yu J; Wang D; Zhang Z; Yang X; Gu Z; Zhao Y
    Biomaterials; 2015 Feb; 40():107-16. PubMed ID: 25433607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs.
    Tian G; Yin W; Jin J; Zhang X; Xing G; Li S; Gu Z; Zhao Y
    J Mater Chem B; 2014 Mar; 2(10):1379-1389. PubMed ID: 32261453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles.
    Liang L; Lu Y; Zhang R; Care A; Ortega TA; Deyev SM; Qian Y; Zvyagin AV
    Acta Biomater; 2017 Mar; 51():461-470. PubMed ID: 28063989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seeing, Targeting and Delivering with Upconverting Nanoparticles.
    Jalani G; Tam V; Vetrone F; Cerruti M
    J Am Chem Soc; 2018 Sep; 140(35):10923-10931. PubMed ID: 30113851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunolabeling and NIR-excited fluorescent imaging of HeLa cells by using NaYF(4):Yb,Er upconversion nanoparticles.
    Wang M; Mi CC; Wang WX; Liu CH; Wu YF; Xu ZR; Mao CB; Xu SK
    ACS Nano; 2009 Jun; 3(6):1580-6. PubMed ID: 19476317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-infrared light triggered photodynamic therapy in combination with gene therapy using upconversion nanoparticles for effective cancer cell killing.
    Wang X; Liu K; Yang G; Cheng L; He L; Liu Y; Li Y; Guo L; Liu Z
    Nanoscale; 2014 Aug; 6(15):9198-205. PubMed ID: 24980695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled siRNA Release of Nanopolyplex for Effective Targeted Anticancer Therapy in Animal Model.
    Jia J; Yang J; Qian L; Zhou B; Tang X; Liu S; Wu L; Chen J; Kuang Y
    Int J Nanomedicine; 2024; 19():1145-1161. PubMed ID: 38344438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles.
    Le XT; Youn YS
    Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicolor tunability and upconversion enhancement of fluoride nanoparticles by oxygen dopant.
    Niu W; Wu S; Zhang S; Su LT; Tok AI
    Nanoscale; 2013 Sep; 5(17):8164-71. PubMed ID: 23887282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-Infrared-Sensitive Materials Based on Upconverting Nanoparticles.
    Wu S; Butt HJ
    Adv Mater; 2016 Feb; 28(6):1208-26. PubMed ID: 26389516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional BaYbF
    Li X; Yi Z; Xue Z; Zeng S; Liu H
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():510-516. PubMed ID: 28415493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dispersion stability and biocompatibility of four ligand-exchanged NaYF
    Chen Y; D'Amario C; Gee A; Duong HTT; Shimoni O; Valenzuela SM
    Acta Biomater; 2020 Jan; 102():384-393. PubMed ID: 31794872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-Infrared-Triggered Upconverting Nanoparticles for Biomedicine Applications.
    Mahata MK; De R; Lee KT
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34210059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 808 nm photocontrolled UCL imaging guided chemo/photothermal synergistic therapy with single UCNPs-CuS@PAA nanocomposite.
    Liu B; Li C; Xie Z; Hou Z; Cheng Z; Jin D; Lin J
    Dalton Trans; 2016 Aug; 45(33):13061-9. PubMed ID: 27529086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lanthanide-Doped Upconversion Nanoparticles: Emerging Intelligent Light-Activated Drug Delivery Systems.
    Bagheri A; Arandiyan H; Boyer C; Lim M
    Adv Sci (Weinh); 2016 Jul; 3(7):1500437. PubMed ID: 27818904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymer-coated NaYF₄:Yb³⁺, Er³⁺ upconversion nanoparticles for charge-dependent cellular imaging.
    Jin J; Gu YJ; Man CW; Cheng J; Xu Z; Zhang Y; Wang H; Lee VH; Cheng SH; Wong WT
    ACS Nano; 2011 Oct; 5(10):7838-47. PubMed ID: 21905691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.